The novel approach of the medication represents a significant advance in the handling of the condition. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide981622.dbblog.net/15359241/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment